# FDA Inspection 848169 - Biomat USA, Inc. - August 16, 2013

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/be0ccd42-bd2d-42b8-92ff-f180656d29cf
Source feed: FDA_Inspections

> FDA Inspection 848169 for Biomat USA, Inc. on August 16, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 848169
- Company Name: Biomat USA, Inc.
- Inspection Date: 2013-08-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1105504 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1912e01b-ce8e-44de-a3ea-5538472b4ced)
- [FDA Inspection 832517 - 2013-04-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0ed8719c-b3e9-4a8b-8810-ee249fdddd0f)
- [FDA Inspection 747581 - 2011-09-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/09f09b8d-6067-4b2a-8081-6f2b002f7bb6)
- [FDA Inspection 573528 - 2009-04-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ae8db929-298c-4d0d-872c-bbe256abcd7c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/3b6f66e1-640f-4863-9d62-a11ab82787f7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d